[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350470-105":59,"doc-detail-350470-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","combination-of-metformin-and-parthenolide-inhibits-breast-cancer-in-mice-by-apoptosis-induction-and-angiogenesis-inhibition","Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition","","Metformin (MET) and parthenolide (PAR), known for antidiabetic and anti-inflammatory actions respectively, are evaluated for their combined anticancer potential against breast cancer in vitro and in vivo. Breast cancer cell lines are tested using the MTT assay to quantify antiproliferative effects, while synergy is analyzed by isobolographic calculation of the combination index. Apoptosis is assessed via caspase-3 activity and angiogenesis via VEGF levels, and in mice via tumor growth monitoring. Results show synergistic growth inhibition, enhanced caspase-3-dependent apoptosis, reduced VEGF expression, significant tumor size reduction, a 50% cure rate, and no treatment-related mortality, with liver and kidney safety markers staying within normal ranges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/combination-of-metformin-and-parthenolide-inhibits-breast-cancer-in-mice-by-apoptosis-induction-and-angiogenesis-inhibition/350470/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/combination-of-metformin-and-parthenolide-inhibits-breast-cancer-in-mice-by-apoptosis-induction-and-angiogenesis-inhibition/350470.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the aim of combining metformin and parthenolide in this study?","Question",{"text":112,"@type":113},"To evaluate whether the combination exerts anticancer activity against breast cancer both in vitro and in vivo.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were antiproliferative effects and drug synergy measured?",{"text":117,"@type":113},"Antiproliferative effects of MET, PAR, and the combination were assessed using the MTT assay, and synergy was quantified using the isobolographic method to calculate the combination index (CI).",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms did the combination affect regarding apoptosis and angiogenesis?",{"text":121,"@type":113},"The combination significantly induced caspase-3-dependent apoptosis and reduced VEGF expression compared with either agent alone.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350470,1790669375,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 10 June 2026  \nDOI 10.3389/fimmu.2026.1843223  \nOPEN ACCESS  \nEDITED BY  \nWenlong Wang,  \nPingdingshan University, China  \nREVIEWED BY  \nSantosh K Maurya,  \nHebrew University of Jerusalem, Israel Govinda Duddukuri,  \nCUKerala, India  \n*CORRESPONDENCE  \nWamidh H Talib  \n[w_talib@asu.edu.jo](w_talib@asu.edu.jo)  \nRECEIVED 30 March 2026  \nREVISED 30 April 2026  \nACCEPTED 22 May 2026  \nPUBLISHED 10 June 2026  \nCITATION  \nAlomari RK, Alasmari MM, Alshaeri HK, Makai A, Talib WH and Hock M (2026) Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition.  \nFront. Immunol. 17:1843223 .  \ndoi: 10.3389/fimmu.2026.1843223  \nCOPYRIGHT  \n© 2026 Alomari, Alasmari, Alshaeri, Makai, Talib and Hock. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCombination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition  \nRaghad K. Alomari 1, Moudi M Alasmari 2,3, Heba K Alshaeri 4, Alexandra Makai 5,6, Wamidh H Talib 7* and M´arta Hock 5,6  \n1 Faculty of Pharmacy, Applied Science Private University, Amman, Jordan, 2College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Jeddah, Saudi Arabia, 3 King Abdullah International Medical Research Centre (KAIMRC), Jeddah, Saudi Arabia, 4 Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia, 5 Institute of Physiotherapy and Sports Science, Faculty of Health Sciences, University of Pe´ cs, Pe´cs, Hungary,  \n6 Physical Activity Research Group, J´anos Szent´agothai Research Center, University of Pe´cs,  \nPe´cs, Hungary, 7 Faculty of Allied Medical Sciences, Applied Science Private University, Amman, Jordan  \nBackground: Metformin (MET), a widely used antidiabetic agent, and parthenolide (PAR), a natural compound recognized for its anti-inﬂammatory properties, have both been extensively explored for their anticancer potential. The present study aimed to investigate the anticancer activity of their combination against breast cancer in vitro and in vivo.  \nMethods: The antiproliferative effects of MET, PAR, and their combination were evaluated against a panel of breast cancer cell lines (EMT6/P, MDA-MB-231, and T47D) using the MTT assay. Synergistic interactions were assessed using the isobolographic method to calculate the combination index (CI) . Apoptosis and angiogenesis were further investigated in T47D cells through caspase-3 activity assays and measurement of vascular endothelial growth factor (VEGF) levels, respectively. For in vivo assessment, EMT6/P cells were inoculated in BALB/cmice, and the antitumor effects of MET, PAR, and their combination were evaluated by monitoring tumor size. Treatment-related toxicity was assessed by measuring serum levels of aspartate transaminase (AST), alanine transaminase (ALT), and creatinine.  \nResults: MET and PAR exhibited a clear synergistic antiproliferative interaction against all tested breast cancer cell lines, with varying degrees of synergism observed. In vivo, combination therapy produced a signiﬁcant reduction in tumor size, with a cure rate of 50% and zero treatment-related mortality. The combination signiﬁcantly induced caspase-3-dependent apoptosis and reduced VEGF expression compared to either agent alone. Serum AST, ALT, and creatinine levels in combination-treated tumor-bearing mice remained within normal ranges, supporting the safety of this regimen.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclus","cbCaim8qq2qI7l53","https://ap.wps.com/l/cbCaim8qq2qI7l53","pdf",2663746,12,"English","# Background\n# Methods\n## Antiproliferative and synergy assessment\n## Apoptosis and angiogenesis evaluation\n## In vivo antitumor and toxicity assessment\n# Results\n# Conclusion","[{\"question\":\"What was the aim of combining metformin and parthenolide in this study?\",\"answer\":\"To evaluate whether the combination exerts anticancer activity against breast cancer both in vitro and in vivo.\"},{\"question\":\"How were antiproliferative effects and drug synergy measured?\",\"answer\":\"Antiproliferative effects of MET, PAR, and the combination were assessed using the MTT assay, and synergy was quantified using the isobolographic method to calculate the combination index (CI).\"},{\"question\":\"What mechanisms did the combination affect regarding apoptosis and angiogenesis?\",\"answer\":\"The combination significantly induced caspase-3-dependent apoptosis and reduced VEGF expression compared with either agent alone.\"}]","Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition | PDF",1790089213,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bca97af0497e0ea9191f9e9420393687.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b303ece0bd3cf5101ba39e88981d7111.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab5a6269846d922223c0f5b15e79b598.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89db8bff3357f537f4ad79dddef260b6.webp",980,1385]